FBP1 and neoplasm: In a multivariate analysis of the entire cohort (taking into account the tumor stages and the nodal stage), FBP1 turned out to be an independent biomarker associated with a favorable prognosis (HR 0.762, 95% CI 0.589, 0.986; p value 0.039, Table 2).